terapia antipiastrinica in casi specifici: anziani, dm ... · mi/stroke/cv death within 30 days...
TRANSCRIPT
![Page 1: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/1.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI:ANZIANI,DM,IRC,NONRIVASCOLARIZZATI
Dr.ssaBuscemiMarialauraDivisionediCardiologiaAziendaOspedalieraSS.AntonioeBiagioeC.Arrigo
![Page 2: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/2.jpg)
CASISPECIFICI?§ Anziani(>75aa)rappresentanoil25%dellapopolazioneconSCA
§ Il30-40%deipazienGricoveraGperSCApresentanoIRCedil20-30%èdiabeGco
§ PazienGnonrivascolarizzaG:40%dellapopolazioneconSCA
Ø OgnigiornocitroviamoadaffrontaredecisioniterapeuGcheinquestedelicatecategoriedipazienG
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 3: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/3.jpg)
ANALOGIE/DIFFERENZETRAIBLOCCANTIRECETTORIALIDELL’ADPRACCOMANDATI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 4: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/4.jpg)
CURE:DISEGNODELLOSTUDIO
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Clopidogrel 75mg q.d. + ASA 75-325
mg q.d.* (6259 patients)
Placebo + ASA 75-325 mg q.d.* (6303 patients)
Patients with Acute Coronary
Syndrome
(unstable angina or non-ST-segment
elevation MI)
R
R = Randomization * In combination with other standard therapy The CURE Trial Investigators. N Engl J Med. 2001;345:494-502.
3 months ≤ double-blind treatment ≤ 12 months
Clopidogrel 300 mg loading dose
![Page 5: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/5.jpg)
PRIMARYENDPOINT-MI/STROKE/CVDEATH
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Clopidogrel + ASA*
3 6 9
Placebo + ASA*
Months of Follow-Up
11.4%
9.3%
20% RRR P < 0.001
N = 12,562
0 12
* In combination with standard therapy The CURE Trial Investigators. N Engl J Med. 2001;345:494-502.
![Page 6: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/6.jpg)
MI/STROKE/CVDEATHWITHIN30DAYS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Clopidogrel + ASA*
10 20 30
Placebo + ASA*
Days of Follow-Up
0
21% RRR P = 0.003
N = 12,562
* In combination with standard therapy The CURE Trial Investigators. N Engl J Med. 2001;345:494-502.
![Page 7: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/7.jpg)
Placebo + ASA
N = 6303
Clopidogrel + ASA
N = 6259 End Point
Majorbleeding 2.7% 3.7%
Life-threateningbleeding 1.8% 2.2%
Non-life-threateningbleeding 0.9% 1.5%
Minorbleeding 2.4% 5.1%
The CURE Trial Investigators. N Engl J Med. 2001;345:494-502.
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
BLEEDINGRESULTS
![Page 8: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/8.jpg)
CLOPIDOGREL:VARIABILITA’DIRISPOSTA
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Serebruany,JACC2005
![Page 9: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/9.jpg)
NUOVIANTIAGGREGANTI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
!"##$
!"#!$
%&'$()*+,-.*&-&*$(/&)*0$
!"##$
!"#!$
%&'$()*+,-.*&-&*$(/&)*0$
![Page 10: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/10.jpg)
TRITON-TIMI38:studydesignandprimaryefficacyendpoints
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
& Planned PCI
ASA
ASA
Primaryefficacyendpoint:acompositeoftherateofdeathfromcardiovascularcauses,nonfatalMI,ornonfatalstroke
=
UA/NSTEMI (TIMI Risk Score ≥ 3)
STEMI (Primary PCI ≤ 12 hours of symptoms or post-STEMI within 14 days)
R
Prasugrel60mgLD/10mgMD
Clopidogrel300mgLD/75mgMD
Keysecondaryendpointsat30and90daysincludedprimaryefficacyendpointandacompositeoftherateofdeathfromcardiovascularcauses,nonfatalMI,orUTVR
=
14.5monthactualmedian
12.0monthplannedmedian
Double-blindtreatment6-15monthsplannedfollow-up
Keysafetyendpoint:non-CABGrelatedTIMIMajorBleeding
WivioeSDetal.NewEnglJMed2007;357:2001-2015WivioeSDetal.AmHeartJ2006;152:627-635
![Page 11: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/11.jpg)
PRIMARYENDPOINTCVDEATH,MI,STROKE
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
0
5
10
15
0 30 60 90 180 270 360 450
HR 0.81 (0.73-0.90) P=0.0004
Prasugrel
Clopidogrel
HR 0.80 P=0.0003
HR 0.77 P=0.0001
Days
Prim
ary
End
poin
t (%
)
12.1 (781)
9.9 (643)
NNT= 46
ITT=13,608 LTFU=14(0.1%)
![Page 12: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/12.jpg)
STENTTHROMBOSIS(ARCDEFINITE+PROBABLE)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
0
1
2
0 30 60 90 180 270 360 450
HR 0.48 P <0.0001
Prasugrel
Clopidogrel 2.4 (142)
NNT= 77
1.1 (68)
Days
End
poin
t (%
) AnyStentatIndexPCIN=12,844
![Page 13: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/13.jpg)
TRITON-TIMI38:RATESOFKEYSTUDYENDPOINTS(ALLACS)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
CABG=CoronaryArteryBypassGrahsurgery;CV=Cardiovascular;MI=MyocardialInfarcGon;TIMI=ThrombolysisInMyocardialInfarcGon
Prasugrel
Clopidogrel
WivioeSDetal.NewEnglJMed2007;357:2001-2015
5
10
15
00 30 60 90 180 270 360 450
Days After Randomization
End
Poi
nt (%
)
120
1.8 (n=111)
2.4 (n=146)
Non-CABG TIMI Major Bleeds
CV Death, MI, Stroke
P=0.03
P<0.001 ↓138 events
↑ 35 events
12.1 (n=781)
9.9 (n=643)
Prasugrel
Clopidogrel
![Page 14: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/14.jpg)
NETCLINICALBENEFITDEATH,MI,STROKE,MAJORBLEED(NONCABG)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
0
5
10
15
0 30 60 90 180 270 360 450Days
HR 0.87 P=0.004
13.9
12.2
Prasugrel
Clopidogrel ITT=13,608
AllCauseMortalityClop3.2%Pras3.0%P=0.64
End
Poi
nt (%
)
![Page 15: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/15.jpg)
PLATOSTUDYDESIGN
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Primaryendpoint:CVdeath+MI+Stroke
Primarysafetyendpoint:Totalmajorbleeding
6–12-monthexposure
Clopidogrel(n=9291)Ifpre-treated,noaddiGonalloadingdose;ifnaive,standard300mgloadingdose,
then75mgqdmaintenance;(addiGonal300mgallowedprePCI)
Ticagrelor(n=9333)180mgloadingdose,then90mgbidmaintenance;(addiGonal90mgpre-PCI)
NSTE-ACS(moderate-to-highrisk)STEMI(ifprimaryPCI)Clopidogrel-treatedor-naive;
randomisedwithin24hoursofindexevent(N=18,624)
![Page 16: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/16.jpg)
PLATOMAINENDPOINTS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
No. at risk
Clopidogrel
Ticagrelor 9,291
9,333
8,521
8,628
8,362
8,460
8,124
Months
6,743
6,743
5,096
5,161
4,047
4,147 8,219
0 2 4 6 8 10 12
12
11
10
9
8
7
6
5
4
3
2
1
0
13
K-M
est
imat
ed ra
te (
% p
er y
ear)
9.8
11.7
HR 0.84 (95% CI 0.77–0.92), p=0.0003
Clopidogrel
Ticagrelor
WallenGnetal.,NewEngJMed.2009;361:1045–1057
0 2 4 6 8 10 12
10
5
0
15
Clopidogrel
Ticagrelor
11.20
11.58
HR 1.04 (95% CI 0.95–1.13), p=0.434
K-M
est
imat
ed ra
te (
% p
er y
ear)
Months
Primary safety endpoint Primary efficacy endpoint
9,186
9,235
7,305
7,246
6,930
6,826
6,670 5,209
5,129
3,841
3,783
3,479
3,433 6,545
![Page 17: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/17.jpg)
ALLCAUSEMORTALITY
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
1 2 3 4 5 6 7 8 9 10 11 12
7
6
5
4
3
2
1
0
K-M
est
imat
ed ra
te (%
per
yea
r)
4,201 4,005 3,962 3,876 3,150 2,413 1,993 4,229 4,029 3,989 3,912 3,195 2,471 1,980
Months
No. at risk Ticagrelor Clopidogrel
Clopidogrel
Ticagrelor
4.9
6.0
HR 0.82 (95% CI = 0.68–0.99), p=0.04
![Page 18: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/18.jpg)
ANTIAGGREGANTINELNSTEMI
2014ESC/EACTSGuidelinesonmyocardialrevascularizaCon
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 19: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/19.jpg)
ANTIAGGREGANTINELLOSTEMITRATTATOCONPCI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
2014ESC/EACTSGuidelinesonmyocardialrevascularizaCon
![Page 20: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/20.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
QUALETERAPIAANTIPIASTRINICAORALENEIPAZIENTIANZIANI(>75ANNI)?
![Page 21: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/21.jpg)
ANZIANI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ Lelineeguidasonobasatesutrialcondomsumaschidi60anni.
§ UnaquotamaggioreecrescentedeinostripazienGsonodonnedioltre70anni
§ Bisognatenercontodelleeventualicomorbilità,condizioniassociate(fragilità,declinofunzionaleecogniGvoeladipendenzafisica)
![Page 22: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/22.jpg)
ANZIANI§ PresentaproblemaGchespecifichedaconsiderare,
quali:Ø laridoeamassamagrachepuòcambiareilvolumedidistribuzionedifarmaciidrofilicielipofilici;
Ø ilrallentatotransitointesGnalechepuòcambiarel’assorbimentodeifarmaci;
Ø lapoliterapiachecreaproblemaGchediinterazionifarmacologiche;
Ø lecomorbilità,comeladisfunzionerenalechepuòdeterminarel’accumulodifarmacieliminaGperviarenale
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 23: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/23.jpg)
QUALESTRATEGIAFARMACOLOGICANEIPAZIENTIANZIANI?
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ CURE:rispeeoaipazienGpiùgiovanilariduzionedelRRdell’incidenzadiendpointprimario(mortevascolare,infartomiocardicoedictus)èrisultataesserepiùaeenuatanell’anziano(13vs29%),anchesepoiciòsitraducevainunasimileriduzionedelrischioassoluto(2.0vs2.2%)
§ DiversistudiosservazionaliefarmacodinamicisuggerisconochetraipazienGanzianiaumentalaresistenzaalclopidogrel
![Page 24: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/24.jpg)
TRITONTIMI38POST-HOCANALYSIS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
BENEFICIOCLINICONETTO:SOTTOGRUPPIADELEVATORISCHIODISANGUINAMENTO
WivioeSetal.NEnglJMed2007:2001-15
![Page 25: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/25.jpg)
PRASUGRELTRILOGYACS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 26: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/26.jpg)
TRILOGYACS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 27: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/27.jpg)
PLATOELDERLYPATIENTSUBGROUPANALYSIS:AGE,TREATMENTANDCVTHROMBOTICOUTCOMES
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Events, n Ticagrelor, %
(n=9333) Clopidogrel, %
(n=9291) p for interaction
CV death, MI or stroke ≥75 years old <75 years old
All-cause mortality ≥75 years old <75 years old MI ≥75 years old <75 years old CV death ≥75 years old <75 years old Definite stent thrombosis ≥75 years old <75 years old
471 1399
17.2 8.6
18.3 10.4
293 608
9.8 3.6
12.4 4.8
241 864
9.3 5.4
9.4 6.6
242 549
8.1 3.3
10.3 4.2
25
141
1.8 1.3
2.1 1.9
Ticagrelor better Clopidogrel better
0.22
0.78
0.25
0.90
0.94
0.5 1.0 2.0 0.3 1.5
![Page 28: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/28.jpg)
PLATOELDERLYPATIENTSUBGROUPANALYSIS:ASSOCIATIONOFAGEANDTREATMENTWITHCLINICALOUTCOMES
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
TheriskofbleedingeventsinbothyoungandelderlypaientsisconsistentwiththatobservedintheoverallPLATOtrial[WallenGn2009:I;Husted2011:F,K]
Nointeracionbetweenageandtreatmentwasobserved
Events, n Ticagrelor, %
(n=9333) Clopidogrel, %
(n=9291) p for interaction
Major bleeding ≥75 years old <75 years old
341 1545
14.2 11.2
13.5 10.8
Non-CABG-related major bleeding ≥75 years old <75 years old
183 482
8.3 3.9
7.1 3.2
CABG, coronary artery bypass graft; CI, confidence interval; HR, hazard ratio. Wallentin L, et al. N Engl J Med 2009;361:1045–1057;
Husted S, et al. J Am Coll Cardiol 2011;57:E1099.
Ticagrelor better Clopidogrel better
1.00
0.78
1.0 2.0 0.5 1.5
![Page 29: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/29.jpg)
…QUINDINELPZ>75ANNI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
• Ticagrelor>(o=)Clopidogrel• Prasugrel5mg=Clopidogrel• Prasugrel10mg<Clopidogrel
![Page 30: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/30.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
QUALETERAPIAANTIPIASTRINICAORALENEIPAZIENTIDIABETICI?
![Page 31: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/31.jpg)
DIABETICI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ pazienGaffemdaSCAdiabeGcihannotassodimortalitàpiùelevatorispeeoainondiabeGci
§ l’alterazionedelmetabolismoglucidico,l’insufficienzadell’azioneinsulinica,molteplicicondizionimetabolicheedaltreanomaliecellulari(es.aumentatoturnoverpiastrinico,upregulaGondelsegnaleP2Y12estressossidaGvo)provocanoun’intensaamvazionedell’aggregazionepiastrinica
§ resistenzaaifarmacianGaggreganGpiastrinicialmeno4-5voltemaggiorerispeeoainondiabeGci
![Page 32: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/32.jpg)
TRITON-TIMI38.PAZIENTIDIABETICI.N=3146
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
0
2
4
6
8
10
12
14
16
18
0 30 60 90 180 270 360 450
HR 0.70 P<0.001
Days
End
poin
t (%
)
CV Death / MI / Stroke
TIMI Major NonCABG Bleeds
NNT = 21
17.0
12.2
Prasugrel
Clopidogrel
Prasugrel
Clopidogrel 2.6 2.5
![Page 33: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/33.jpg)
SOTTOSTUDIODELPLATO.PAZIENTIDIABETICI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Ticagrelor Clopidogrel
N. a rischio 2326 2113 2045 1959 1593 1199 953 2336 2084 2041 1968 1604 1225 975 6999 6507 6407 6252 5143 3955 3191 6952 6434 6318 6153 5044 3869 3097
Incidenza cumulativa dell’endpoint primario (morte CV, IM, ictus)
End
poin
t prim
ario
0 0
10
5
60 120 240 300 Giorni dalla randomizzazione
20
15
360 180
No diabete Ticagrelor Clopidogrel
Diabete
Fig. 1A e Tab. 4, Rif. g13
Non diabetici: HR: 0,83; IC 95%: 0,74-0,93 (RRR=17%)
Ticagrelor:180mg(dosedacarico),quindi90mgBIDClopidogrel:300-600mg(dosedacarico),quindi75mgOD
Dosiaddizionali:300mgdiclopidogrelprimadellaPCI
Diabetici: HR: 0,88; IC 95%: 0,76-1,03 (RRR=12%)
HbA1c ≥ 6,0% HbA1c < 6,0%
p=0,24
RRR 7%
RRR 20%
HbA1c < 6,0%: ticagrelor 8,2%, clopidogrel 9,0%; HR: 0,93; IC 95%: 0,79-1,09 HbA1c ≥ 6,0%: ticagrelor 11,4%, clopidogrel 14,2%; HR: 0,80; IC 95%: 0,70-0,91
16,2
8,4 10,2
14,1
![Page 34: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/34.jpg)
…QUINDIINPZDIABETICI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ Ticagrelor>Clopidogrel§ Prasugrel>>Clopidogrel
![Page 35: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/35.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
QUALETERAPIAANTIPIASTRINICAORALENEIPAZIENTICONINSUFFICIENZARENALE?
![Page 36: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/36.jpg)
INSUFFICIENZARENALECRONICA
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ PazienGconSCAeinsufficienzarenalepresentano:
Ø piùaltamortalità,rischioischemicoerischioemorragicoetalerischioaumentainmanieraesponenzialeneipazienGconfiltratoglomerulare≤30ml/min/1.73m2
Ø rischioditrombosidistentdocumentataoprobabilecirca3.5voltesuperioreallostandard
![Page 37: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/37.jpg)
ANTIAGGREGANTIEINSUFFICIENZARENALE
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
MontalescotCirculaGonsept142010
![Page 38: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/38.jpg)
…QUINDIINPZCONINSUFFICIENZARENALE
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ Ticagrelor>>Clopidogrel§ Prasugrel>=Clopidogrel
![Page 39: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/39.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
QUALETERAPIAANTIPIASTRINICANEIPAZIENTINONRIVASCOLARIZZATI?
![Page 40: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/40.jpg)
NONRIVASCOLARIZZATI§ RecenGregistriinternazionalihannodocumentatoche
circail40%deipazienGricoveraGcondiagnosidiSCAricevonountraeamentoconservaGvo
§ duepopolazionidisGnte:Ø pazienGche,acausadelRelevato(pazienGfragiliconmulGplecomorbilità)otroppobasso,nonsononeanchesoeoposGadesamecoronarografico;
Ø pazienGchedopolacoronarografianonvengonorivascolarizzaGperillororischioanatomicotroppobasso(coronaropaGasubcriGcaomalamaostrumvadiunvasosecondario)o,incasipiùrari,perlapresenzadiunacoronaropaGaostrumvatalmenteseveraedestesadaesseregiudicatanonrivascolarizzabile. "
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 41: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/41.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
ComorbiditiesPatient refusalRevasc.unsuitableDNR statusAdvanced ageActive bleeding Other
20%
18%
17% 16%
11%
4%
14%
ReasonsforcontraindicaionstocardiaccatheterizaionintheCRUSADERegistry
Comorbidiies
![Page 42: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/42.jpg)
(CV death, MI,stroke)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 43: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/43.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 44: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/44.jpg)
PRASUGRELTRILOGYACS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
HR0.91(95%CI,0.79to1.05)p=0.21 HR0.93(95%CI,0.75to1.15)
![Page 45: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/45.jpg)
non inv
HR 0,85 (0,73-1,00), p = 0,045 HR 0,75 (0,61-0,93), p = 0,010
non inv
![Page 46: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/46.jpg)
HR 1,17 (0,98-1,39), p = 0,079
![Page 47: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/47.jpg)
…NELL’UA/NSTEMIESTRATEGIACONSERVATIVA
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
§ Ticagrelor>Clopidogrel§ Prasugrel<o=Clopidogrel
![Page 48: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/48.jpg)
SCELTAANTIAGGREGANTESECONDOG.L.ESC/AHA/ACC
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
*Prasugrelinassenzacontroindicazioni(stroke/TIA) S.D.WivioeLANCETMarch2015
![Page 49: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/49.jpg)
CONCLUSIONI:comemicomportonellapraicaclinica?
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Clopidogrel Prasugrel Ticagrelor
STEMIePCIprimaria + ++ ++UA/NSTEMIePCI + ++ ++UA/NSTEMIestrategiaconservaGva + - ++>75anni + + +(+)DiabeGci + ++ ++PzconTIA/stroke + - +Insufficienzarenale<60ml/min + + ++
![Page 50: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/50.jpg)
GRAZIEDELL’ATTENZIONE
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 51: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/51.jpg)
![Page 52: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/52.jpg)
![Page 53: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/53.jpg)
![Page 54: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/54.jpg)
![Page 55: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/55.jpg)
SOTTOANALISIDELLOSTUDIOTRITON-TIMI38EVENTICLINICICORRELATIALLOSTATODID.M.
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
WivioeSD,NEnglJMed2007;357(20):2001-15
![Page 56: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/56.jpg)
Ratesofcardiovasculardeath,nonfatalmyocardialreinfarcion,nonfatalstroke,andmajorbleedingwithinthefollow-upperiodinpaientsaged>75yearsenrolledinthePLATO5andTRITON-TIMI386trials.
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 57: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/57.jpg)
JukemaJW,CurrentMedicalResearch&Opinion Vol.28,No.2,2012,203–211,
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 58: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/58.jpg)
CONCLUSIONI:RUOLONUOVIANTIAGGREGANTI
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
TICAGRELOR PRASUGRELRIVASCOLARIZZAZIONE
TERAPIAMEDICADIABETICI
PRETRATTAMENTOINSUFF.RENALE
ANZIANIPESO
STROKE/TIAISCHEMICOTAO/NAOMORTALITA’
![Page 59: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/59.jpg)
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 60: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/60.jpg)
SITID’AZIONEDELTRATTAMENTOANTIPIASTRINICOYousufO,BhaeDL.NatRevCardiol2011:doi:10.1038/nrcardio.2011.96
YousufO,BhaeDL.NatRevCardiol2011:doi:10.1038/nrcardio.2011.96TargetedanGplatelettherapies
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
![Page 61: TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI: ANZIANI, DM ... · MI/STROKE/CV DEATH WITHIN 30 DAYS TERAPIA ANTIPIASTRINICA IN CASI SPECIFICI Dr.ssa Buscemi Marialaura Clopidogrel + ASA*](https://reader034.vdocuments.us/reader034/viewer/2022042919/5f619c846c6e265656026aab/html5/thumbnails/61.jpg)
COMPARINGMEANAGESOFITALIANACSREGISTRIESANDGUIDELINE-BUILDINGTRIALS
TERAPIAANTIPIASTRINICAINCASISPECIFICI Dr.ssaBuscemiMarialaura
Eur Heart J Acute CV Care
2012
80-
75-
70-
65-
60-
55-
NSTEACS STEMI
74 68
BLITZ 4
women
men
Eur Heart J Acute CV Care
2012
68 63
BLITZ 4
women
men
62 62 62
RITA III
Lancet 2002
TIMI 18
NEJM 2001
ICTUS NEJM 2005
60 59
TRITON Lancet 2009
HORIZONS NEJM 2008
PLATO Circulation
2011
59
years
SavonieoS.RevEspCardiol2014;67:564
COURAGEmeanage62SINTAXmeanage65BESTmeanage64